Cardinal Health Inc. (CAH)
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, Cardinal Health (CAH) stood at $230.11, denoting a -1.52% move from the preceding trading day.
Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Should You Retain CAH Stock After Removal From Several Russell Indices?
CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from its prior day's close.
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating
Cardinal Health receives a Buy rating, supported by defensive business fundamentals, strong adjusted EPS growth, and strategic expansion into specialty healthcare. CAH's Q3FY26 showed 11% revenue growth and 35% adjusted EPS growth, though GAAP results were pressured by higher costs and special items. Valuation is at a premium with a Forward P/E of 21.64x, justified by improving profitability and cash flow, but future upside depends on sustained margin gains.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
